ESAB’s Q3 results for 2025 came in above Wall Street’s revenue and profit expectations, but the market reacted negatively, likely due to margin pressures and investor concerns around cost headwinds. Management pointed to a return to positive organic growth, especially in the Americas and EMEA/APAC regions, as well as the early completion of the EWM acquisition. CEO Shyam Kambeyanda emphasized operational execution, highlighting new product momentum and the integration of EWM’s advanced welding technologies as key contributors to the quarter. However, ongoing tariff impacts and increased investments in sales initiatives weighed on operating margins.
ESAB (ESAB) Q3 CY2025 Highlights:
- Revenue: $727.8 million vs analyst estimates of $696 million (8.1% year-on-year growth, 4.6% beat)
- Adjusted EPS: $1.36 vs analyst estimates of $1.27 (6.9% beat)
- Adjusted EBITDA: $139.5 million vs analyst estimates of $129.9 million (19.2% margin, 7.4% beat)
- Management slightly raised its full-year Adjusted EPS guidance to $5.25 at the midpoint
- EBITDA guidance for the full year is $537.5 million at the midpoint, in line with analyst expectations
- Operating Margin: 14.6%, down from 15.7% in the same quarter last year
- Organic Revenue rose 1.6% year on year vs analyst estimates of flat growth (116.7 basis point beat)
- Market Capitalization: $6.78 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From ESAB’s Q3 Earnings Call
Bryan Blair (Oppenheimer) asked about the catch-up of deferred automation shipments and the outlook for lingering risks in Mexico. CEO Shyam Kambeyanda explained that only part of the revenue was recovered in Q3 and expects the remainder to be realized in Q4 and Q1.
Bryan Blair (Oppenheimer) inquired about the EWM acquisition’s integration and near-term financial model. CFO Kevin Johnson stated that while initial profit contribution is modest, ongoing investments and emerging synergies should be reflected in guidance updates next year.
Tami Zakaria (JPMorgan) sought clarification on the EBITDA margin decline in the Americas and the impact of tariffs. Kambeyanda confirmed both investment in growth initiatives and late-quarter tariff impacts, with mitigation plans involving manufacturing shifts and restructuring.
Mircea Dobre (Baird) pressed for greater detail on the drivers of expected margin recovery in 2026. Kambeyanda highlighted three levers: ongoing restructuring, improved comparables, and geographic supply chain realignment.
Nathan Jones (Stifel) requested insight into Q4 trends and price/cost dynamics in the Americas. Kambeyanda noted an improving core growth rate in Q4 and expects manufacturing shifts to remove margin drag from tariffs next year.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will focus on (1) the pace and success of EWM integration and cross-selling, (2) whether ESAB can deliver margin recovery in the Americas through restructuring and manufacturing moves, and (3) sustained order momentum in EMEA and APAC, especially in high-growth sectors like infrastructure and defense. Progress on AI-driven workflow solutions and new product adoption will also be important markers of execution.
ESAB currently trades at $111.65, down from $121.19 just before the earnings. Is the company at an inflection point that warrants a buy or sell? .